CDC Bioterrorism Agents
Category A | |
| · Anthrax (Bacillus anthracis) |
| · Botulism (Clostridium botulinum toxin) |
| · Plague (Yersinia pestis) |
| · Smallpox (Variola major) |
| · Tularemia (Francisella tularensis) |
| · Viral hemorrhagic fevers (filoviruses [e.g., Ebola, Marburg] and |
| arenaviruses [e.g., Lassa, Machupo]) |
Category B | |
| · Brucellosis (Brucella species) |
| · Epsilon toxin of Clostridium perfringens |
| · Food safety threats (e.g., Salmonella species, Escherichia coli O157:H7, |
| · Shigella) |
| · Glanders (Burkholderia mallei) |
| · Melioidosis (Burkholderia pseudomallei) |
| · Psittacosis (Chlamydia psittaci) |
| · Q fever (Coxiella burnetii) |
| · Ricin toxin from Ricinus communis (castor beans) |
| · Staphylococcal enterotoxin B |
| · Typhus fever (Rickettsia prowazekii) |
| · Viral encephalitis (alphaviruses [e.g., Venezuelan equine encephalitis, |
| eastern equine encephalitis, western equine encephalitis]) |
| · Water safety threats (e.g., Vibrio cholerae, Cryptosporidium parvum) |
Category C
· Emerginginfectious diseases such as Nipah virusand hantavirus
Category A Diseases/Agents
The U.S. public health systemand primary healthcare providers must be preparedto address various biological agents, including pathogens that are rarely seen in the UnitedStates. High-priority agents include organismsthat pose a risk to national securitybecause they
· can be easily disseminated or transmitted from person to person;
· result in high mortalityrates and have the potential for major public healthimpact;
· might cause public panic and social disruption; and
· require special actionfor public healthpreparedness.
CategoryB Diseases/Agents
Second highest priority agents includethose that
· are moderately easy to disseminate;
· result in moderate morbidity rates and low mortalityrates; and
· require specific enhancements of CDC's diagnostic capacityand enhanced diseasesurveillance.
CategoryC Diseases/Agents
Third highest priority agents includeemerging pathogensthat could be engineered for mass dissemination in the future becauseof
· availability;
· ease of production and dissemination; and
· potential for high morbidityand mortality rates and major health impact.
Citation: CDC| Bioterrorism Agents/Diseases(byCategory) | EmergencyPreparedness & Response (http://www.bt.cdc.gov/agent/agentlist-category.asp)
Comments
Post a Comment